ORLANDO, Fla. - eTradeWire -- The Florida Multiple Sclerosis Conference will take place on Saturday, July 25, 2026, from 7:00 AM to 5:00 PM at the Omni Orlando Resort, 1500 Master Blvd., ChampionsGate, FL 33896. This one-day educational conference is designed for Florida neurologists, advanced practice providers, physician assistants, primary care physicians, MS specialists, and other medical professionals involved in the diagnosis, treatment, and long-term care of patients with Multiple Sclerosis and related demyelinating disorders.

Providers may earn up to 6.5 CME Credits while learning from leading MS experts from institutions across Florida and beyond. The conference will provide practical, clinically relevant education on the evolving landscape of MS care, including early diagnosis, treatment selection, progressive disease, symptom management, imaging, pregnancy and family planning, NMOSD, MOGAD, and emerging therapies.

The program will feature presentations on:

• Early Diagnosis of MS: Biomarkers and Imaging — John Ciotti, MD, University of South Florida
• Treatment Strategies: Early High-Efficacy vs. Escalation — Elsa Rodriguez, MD, Cleveland Clinic
• Progressive MS: Treatment Options — Torge Rempe, MD, PhD, UF Gainesville
• The Expanding Role of Imaging AI in the Diagnosis and Monitoring of MS — Dirk Smeets, PhD, Icometrix, Brussels
• Pregnancy, Family Planning, and MS — Mayra Montalvo, MD, UF Gainesville
• Symptom Management in Multiple Sclerosis — Vanessa Marin Collazo, MD, Mayo Clinic
• Progression Independent of Relapse — Matthew Baker, MD, Collier Neurologic Specialists
• Immune Reconstitution in Aging People with Multiple Sclerosis — Donald Negroski, MD, Negroski Neurology
• HSCT and CAR-T in Multiple Sclerosis — Abu-Sayeef Mirza, MD, Moffitt Cancer Center
• NMOSD and MOGAD — Aisha Elfasi, MD, University of South Florida
• Bridging Academic and Community MS Care in Florida — Freddy Escobar, MD, Orlando Health / UF Gainesville

A key focus of this year's conference will be the rapid advancement of MS research and clinical care, including the growing role of artificial intelligence (AI) in diagnosis, monitoring, and treatment planning. AI-driven tools enable researchers and clinicians to analyze MRI data, biomarkers, clinical records, and large patient datasets, facilitating the identification of disease patterns earlier, supporting more personalized treatment decisions, and enhancing the understanding of MS progression.

More on eTradeWire News

• Bolo the Assassin Surpasses 800 Original Songs
• Qustone Brings Leadership as Infrastructure to the Commercial Space Ecosystem
• Awepra Launches Free OutRun Classic Sega Arcade Game Online — No Ads, No Download Required
• New Children's E-Book and Learning Bundle Helps Young Learners Prepare for Kindergarten
• Rabbi Michael "Moshe" Rothschild (#ViralRabbi) to Join LifePodcast for Special Series on Futurism

The Florida Multiple Sclerosis Conference provides a valuable opportunity for healthcare providers across the state to enhance their clinical knowledge, explore emerging therapies, and collaborate on improving outcomes for patients living with MS.

To learn more about the Florida Multiple Sclerosis Conference, registration, and sponsorship opportunities, visit https://neuroevents.org/